Nurse Practitioner in Middleton, ID Accepting Medicare
6 Nurse Practitioner nurses found. Showing 1 - 6
 Mr. Richard M Mcconkie Jr., NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 381 S Middleton Rd Ste B, Middleton, ID 83644 Phone: 208-585-6311 |
 Suzanne Elise Monaghan, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 381 S Middleton Rd Ste B, Middleton, ID 83644 Phone: 208-585-6311 |
Beverlee K Furner, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 201 S 1st Ave E, Middleton, ID 83644 Phone: 208-585-0048 Fax: 208-585-6242 |
Mrs. Erin Keller, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 201 S. 1st Ave. E, Middleton, ID 83644 Phone: 208-585-6311 Fax: 208-585-6221 |
Jenifer A. Hughes, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 24789 Hartley Ln, Middleton, ID 83644 Phone: 208-484-6091 |
Samuel Hally, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1346 Cimarron Ct, Middleton, ID 83644 Phone: 208-695-8001 |
News Archive
Ferring Pharmaceuticals launches new trial of Degarelix for intermittent androgen deprivation therapy
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
Early testing can help mitigate blood clots related to AstraZeneca/Oxford vaccine
New research has shown that early testing for blood clots in patients who had received the AstraZeneca/Oxford vaccine led to them being treated successfully, highlighting the need for heightened awareness of the risk among doctors.
New publication covers basic and advanced ophthalmic radiation therapy techniques
This publication, a conjoint effort by ocular oncologists and radiation oncologists, comprises ten chapters covering basic and advanced radiation therapy techniques followed by specific indications by location (uveal, retinal, orbital tumors, eyelid and conjunctival tumors) and complications of radiation therapy.
Enrollment completed in Impax Pharmaceuticals' APEX-PD trial of IPX066
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its APEX-PD trial. APEX-PD is a multinational Phase III trial of its late-stage drug candidate IPX066 in subjects with early Parkinson's disease.
Religious leaders must play role in HIV prevention efforts, opinion piece says
Addressing HIV/AIDS at a local level "demands a vigorous response from the faith community," Charles Jackson - pastor of Brookland Baptist Church in West Columbia, S.C. - and John Culp, pastor of Virginia Wingard Memorial United Methodist Church in Columbia, write in a Columbia State opinion piece.
› Verified 2 days ago